| Product NDC: | 17856-0057 |
| Proprietary Name: | Digoxin |
| Non Proprietary Name: | Digoxin |
| Active Ingredient(s): | .05 mg/mL & nbsp; Digoxin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17856-0057 |
| Labeler Name: | Atlantic Biologicals Corps |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021648 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040826 |
| Package NDC: | 17856-0057-1 |
| Package Description: | 2.5 mL in 1 CUP, UNIT-DOSE (17856-0057-1) |
| NDC Code | 17856-0057-1 |
| Proprietary Name | Digoxin |
| Package Description | 2.5 mL in 1 CUP, UNIT-DOSE (17856-0057-1) |
| Product NDC | 17856-0057 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Digoxin |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20040826 |
| Marketing Category Name | NDA |
| Labeler Name | Atlantic Biologicals Corps |
| Substance Name | DIGOXIN |
| Strength Number | .05 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |